DaunoXome offers KS treatment alternative.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D014481:United States; D014486:United States Food and Drug Administration
D000903:Antibiotics, Antineoplastic; D003630:Daunorubicin